Literature DB >> 21696704

The effect of a new syringe design on the ability of rheumatoid arthritis patients to inject a biological medication.

Ali Sheikhzadeh1, Jangwhon Yoon, Dan Formosa, Barbara Domanska, Darrell Morgan, Michael Schiff.   

Abstract

Self-administration of new biological medications can be difficult for Rheumatoid Arthritis patients with functional impairment and hand and dexterity limitation. Twenty-three Rheumatoid Arthritis (RA) patients participated in this study to compare preferences and injection forces using a conventional syringe and a new ergonomically designed syringe. Injection force measurements were collected in two ways: a) isometric forces, with the syringes' plungers in fixed positions (depressed halfway and fully depressed), and b) forces exerted during injection of the medication. Subjects' grip and pinch strengths were measured. A perception questionnaire gauged subjects' impressions and preferences. Subjects were capable of exerting significantly higher isometric forces using the new syringe with the plunger fixed both halfway and fully depressed. During injection of the medication, peak and mean injection forces were significantly higher, and duration was shorter, when using the new syringe. Subjects rated the new syringe higher on all twenty attributes on preference and performance. Therefore, it is expected that the new syringe will benefit self-administration of medication injection for RA patients.
Copyright © 2011 Elsevier Ltd and The Ergonomics Society. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 21696704     DOI: 10.1016/j.apergo.2011.05.014

Source DB:  PubMed          Journal:  Appl Ergon        ISSN: 0003-6870            Impact factor:   3.661


  7 in total

1.  Measuring tissue back-pressure--in vivo injection forces during subcutaneous injection.

Authors:  Andrea Allmendinger; Robert Mueller; Edward Schwarb; Mark Chipperfield; Joerg Huwyler; Hanns-Christian Mahler; Stefan Fischer
Journal:  Pharm Res       Date:  2014-12-24       Impact factor: 4.200

2.  Opportunities in an Evolving Pharmaceutical Development Landscape: Product Differentiation of Biopharmaceutical Drug Products.

Authors:  Andrea Allmendinger
Journal:  Pharm Res       Date:  2021-04-26       Impact factor: 4.200

Review 3.  Challenges and opportunities to include patient-centric product design in industrial medicines development to improve therapeutic goals.

Authors:  Carsten Timpe; Sven Stegemann; Andrew Barrett; Siddharthya Mujumdar
Journal:  Br J Clin Pharmacol       Date:  2020-06-16       Impact factor: 4.335

4.  Chronic Disease and Self-Injection: Ethnographic Investigations into the Patient Experience During Treatment.

Authors:  Michael Schiff; Shane Saunderson; Irina Mountian; Paul Hartley
Journal:  Rheumatol Ther       Date:  2017-09-27

5.  Using Patient Feedback to Optimize the Design of a Certolizumab Pegol Electromechanical Self-Injection Device: Insights from Human Factors Studies.

Authors:  Barbara Domańska; Oliver Stumpp; Steven Poon; Serkan Oray; Irina Mountian; Clovis Pichon
Journal:  Adv Ther       Date:  2017-12-08       Impact factor: 3.845

Review 6.  Practical considerations in clinical strategy to support the development of injectable drug-device combination products for biologics.

Authors:  Zhaoyang Li; Rachael Easton
Journal:  MAbs       Date:  2017-11-07       Impact factor: 5.857

7.  From drug-delivery device to disease management tool: a study of preferences for enhanced features in next-generation self-injection devices.

Authors:  Marco Boeri; Boglarka Szegvari; Brett Hauber; Brennan Mange; Irina Mountian; Michael Schiff; Nikolaos Maniadakis
Journal:  Patient Prefer Adherence       Date:  2019-07-11       Impact factor: 2.711

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.